We identified altered levels of AChE and BChE mRNAs, and modified ACh hydrolytic activity in AD and PD brains reflects a primarily post-transcriptional cholinergic imbalance and highlights both disease- and brain area-specific changes in the post-transcriptional regulation of AChE variants. The gene discussed is ACHE; the disease is Alzheimer disease.